GMM Pfaudler Q4 FY25: Revenue Up 9%, Loss ₹27 Cr

What the March-quarter numbers showed

GMM Pfaudler reported a weak March-quarter set of results even as revenue grew year-on-year. For Q4 FY25, the company posted a consolidated net loss of ₹26.95 crore, versus a net profit of ₹27.63 crore in Q4 FY24. Revenue from operations rose 8.89% year-on-year to ₹806.59 crore from ₹740.73 crore. EBITDA increased 4% year-on-year to ₹93 crore from ₹90 crore. But profitability ratios weakened as the EBITDA margin fell to 11.5% from 12.1% in the year-ago quarter.

Stock reaction and immediate market read-through

The stock fell sharply after the results. GMM Pfaudler tumbled 6.96% to ₹1,177.80 following the Q4 FY25 loss announcement. The decline reflected investor concerns around margin erosion and the swing to a loss despite higher revenue. The quarterly performance also pointed to pressure from utilisation and demand conditions. The market reaction, in this case, tracked the headline bottom line more than the revenue growth.

Margins: why higher sales did not convert to profit

The quarter included elevated one-time costs and macroeconomic challenges, which hit profit margins despite revenue growth. In one performance snapshot shared in the provided data, EBITDA fell 8.3% year-on-year to ₹83.2 crore, and EBITDA margin contracted to 10.3% from 12.1% a year earlier. The same snapshot also cited a net loss of ₹27.9 crore in Q4 FY25 versus a profit of ₹28.7 crore in Q4 FY24. Separately, profit before exceptional items and tax in Q4 FY25 was reported at ₹13.52 crore, down from ₹31 crore a year earlier. Together, these figures indicate that costs and margin compression were the key drivers of the weak bottom line.

Q4 FY25 operational metrics in one view

The company’s own quarterly dashboard in the provided content also captured the pressure points. Revenue rose 9% year-on-year to ₹807 crore, while adjusted EBITDA was ₹93 crore, up 4%. However, EBITDA margin dropped 60 bps to 11.5%, and PAT was shown at ₹15 crore versus ₹25 crore, a 40% decline. Order intake for the quarter was ₹660 crore, down 17% year-on-year from ₹798 crore.

Full-year FY25: revenue down, profit sharply lower

On a full-year basis, the company reported consolidated revenue of ₹3,198.69 crore in FY25, down 7.19% versus FY24. FY25 net profit fell 69.81% year-on-year to ₹52.97 crore, compared with ₹175.47 crore in FY24. Another summary in the provided material reported FY25 consolidated revenue of ₹3,199 crore, EBITDA of ₹381 crore, and an EBITDA margin of 11.9%. Profit after tax excluding exceptional items was cited at ₹100 crore, translating to an EPS of ₹22.99. While the different profit presentations reflect varying treatment of exceptional items, the common thread across disclosures was that profitability was under pressure.

Order book, backlog and cash flow signals

Order momentum was mixed across periods cited in the provided data. For FY25, order intake was reported at ₹3,102 crore, up 3% year-on-year, while order backlog stood at ₹1,636 crore, down 3% year-on-year. Free cash flow was reported at ₹318 crore, up ₹97 crore year-on-year. Another cash-flow line item in the data showed cash flows rising 33% year-on-year to ₹378 crore. Leverage also improved, with a metric noted as improving to 0.2x from 0.4x earlier.

India operations: stronger margins and improving H2

India operations were highlighted as a relative bright spot. In Q4 FY25, India operations reported revenue of ₹252 crore and EBITDA of ₹44 crore, delivering an EBITDA margin of 17.4%. The improvement was attributed to higher volumes, a favourable product mix, and cost optimisation. The company also cited an ongoing EBITDA transformation programme in India, and noted that all costs for this programme were taken in FY25. India backlog was reported at ₹549 crore, up 20% year-on-year.

Segment mix and where the pressure came from

A FY25 revenue split in the provided data showed India (standalone) revenue at ₹921 crore, down 11% year-on-year. International (Mavag and PFI) revenue was reported at ₹2,366 crore, down 9% year-on-year. Standalone EBITDA was ₹130 crore with a margin of 14.1%. International EBITDA dropped to ₹257 crore with a margin of 10.9%, highlighting that profitability pressure was more pronounced outside the India standalone business.

Management commentary: steady delivery, but costs hit margins

Managing Director Tarak Patel said the company delivered steady performance with 10% revenue growth despite global challenges, and highlighted 12% revenue growth and a 40% increase in profit after tax in India business. The company also pointed to diversification and cost optimisation efforts to navigate difficult demand conditions. At the same time, the disclosures acknowledged that elevated one-time costs and macroeconomic challenges significantly hit margins. In another FY26 datapoint included in the provided text, revenue for Q4 FY26 was stated at ₹944 crore, up 17% year-on-year, while full-year order intake rose 20% to ₹3,714 crore and backlog grew 34% to ₹2,194 crore.

Why the results matter for investors

The headline swing to a quarterly loss, combined with margin contraction, is the key near-term signal from Q4 FY25. Order intake and backlog numbers suggest that visibility exists, but the year-on-year decline in backlog in FY25 points to a cautious demand environment in some segments and geographies. India’s Q4 margin of 17.4% stands out versus consolidated margins around the low teens, indicating that mix and execution in India are supporting profitability. The market, however, reacted to the consolidated bottom line and the impact of one-time costs. Future updates on utilisation, cost normalisation, and order conversion will be central to how the stock is priced.

Conclusion

GMM Pfaudler’s Q4 FY25 showed revenue growth but a sharp deterioration in profitability, culminating in a consolidated net loss and a near-7% stock drop. FY25 numbers also reflected a steep decline in reported net profit alongside lower revenue. India operations continued to post stronger margins, supported by mix, volumes, and cost optimisation measures. The next set of disclosures is expected to clarify how one-time costs fade and how the order book converts into revenue and margins.